Compagnie Lombard Odier SCmA’s Lexicon Pharmaceuticals LXRX Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$796K	Buy	510,000 +100,000	+24%	+$145K	0.01%	171
2025 Q4	$472K	Hold	410,000	–	–	0.01%	203
2025 Q3	$554K	Buy	410,000 +80,000	+24%	+$90.8K	0.01%	187
2025 Q2	$312K	Buy	330,000 +220,000	+200%	+$143K	﹤0.01%	207
2025 Q1	$50.7K	Hold	110,000	–	–	﹤0.01%	354
2024 Q4	$81.2K	Buy	110,000 +10,000	+10%	+$12.1K	﹤0.01%	307
2024 Q3	$157K	Buy	100,000 +6,000	+6%	+$10.7K	﹤0.01%	262
2024 Q2	$158K	Hold	94,000	–	–	﹤0.01%	261
2024 Q1	$226K	Hold	94,000	–	–	﹤0.01%	249
2023 Q4	$144K	Hold	94,000	–	–	﹤0.01%	323
2023 Q3	$102K	Hold	94,000	–	–	﹤0.01%	352
2023 Q2	$215K	Hold	94,000	–	–	0.01%	254
2023 Q1	$228K	Sell	94,000 -4,000	-4%	-$9.17K	0.01%	267
2022 Q4	$187K	Hold	98,000	–	–	0.01%	303
2022 Q3	$235K	Hold	98,000	–	–	0.01%	279
2022 Q2	$182K	Buy	98,000 +94,000	+2,350%	+$179K	﹤0.01%	303
2022 Q1	$8K	Hold	4,000	–	–	﹤0.01%	558
2021 Q4	$16K	Hold	4,000	–	–	﹤0.01%	600
2021 Q3	$19K	Hold	4,000	–	–	﹤0.01%	567
2021 Q2	$18K	Hold	4,000	–	–	﹤0.01%	561
2021 Q1	$23K	Hold	4,000	–	–	﹤0.01%	564
2020 Q4	$14K	Hold	4,000	–	–	﹤0.01%	523
2020 Q3	$6K	Hold	4,000	–	–	﹤0.01%	490
2020 Q2	$8K	Hold	4,000	–	–	﹤0.01%	485
2020 Q1	$8K	Hold	4,000	–	–	﹤0.01%	446
2019 Q4	$17K	Sell	4,000 -1,500	-27%	-$5.77K	﹤0.01%	425
2019 Q3	$17K	Hold	5,500	–	–	﹤0.01%	429
2019 Q2	$34K	Hold	5,500	–	–	﹤0.01%	389
2019 Q1	$30K	Hold	5,500	–	–	﹤0.01%	438
2018 Q4	$37K	Hold	5,500	–	–	﹤0.01%	406
2018 Q3	$59K	Hold	5,500	–	–	﹤0.01%	407
2018 Q2	$66K	Hold	5,500	–	–	﹤0.01%	403
2018 Q1	$47K	Sell	5,500 -2,500	-31%	-$23.1K	﹤0.01%	461
2017 Q4	$80K	Buy	8,000 +6,200	+344%	+$64.4K	﹤0.01%	500
2017 Q3	$22K	Hold	1,800	–	–	﹤0.01%	599
2017 Q2	$30K	Sell	1,800 -700	-28%	-$10.8K	﹤0.01%	578
2017 Q1	$36K	Buy	2,500 +1,800	+257%	+$26.7K	﹤0.01%	576
2016 Q4	$10K	Hold	700	–	–	﹤0.01%	749
2016 Q3	$13K	Hold	700	–	–	﹤0.01%	823
2016 Q2	$10K	Sell	700 -3,871	-85%	-$52.5K	﹤0.01%	830
2016 Q1	$55K	Sell	4,571 -3,000	-40%	-$31.5K	﹤0.01%	701
2015 Q4	$101K	Buy	+7,571	New	+$93.1K	﹤0.01%	594
2015 Q2	–	Sell	-7,571	Closed	-$50K	–	893
2015 Q1	$50K	Hold	7,571	–	–	﹤0.01%	785
2014 Q4	$48K	Buy	+7,571	New	+$61K	﹤0.01%	635

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Sessa Capital New York $5.26B AUM 47.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return